Previous Section
Clinical Trials
61. Phase II trial of thalidomide as maintenance therapy for extensive stage small cell lung cancer after response to chemotherapy.
- Author
- Dowlati A; Subbiah S; Cooney M; Rutherford K; Mekhail T; Fu P; Chapman R; Ness A; Cortas T; Saltzman J; Levitan N; Warren G;
- Institution
- Division of Hematology/Oncology, Case Western Reserve University and University Hospitals of Cleveland, CASE Comprehensive Cancer Center, Cleveland, Ohio 44106, USA. afshin.dowlati@case.edu
- Journal
- Lung Cancer. 2007 Jun;56(3):377-81. Epub 2007 Feb 27.
- Abstract URL
- Click here to view abstract
62. Phase II study of amrubicin, 9-amino-anthracycline, in patients with advanced non-small-cell lung cancer: a West Japan Thoracic Oncology Group (WJTOG) study.
- Author
- Takeda K; Takifuji N; Negoro S; Furuse K; Nakamura S; Takada Y; Hoso T; Hayasaka S; Nakano T; Araki J; Senba H; Iwami F; Yamaji Y; Fukuoka M; Ikegami H;
- Institution
- Department of Clinical Oncology, Osaka City General Hospital, 2-13-22, Miyakojimahondohri, Osaka 5340021, Japan. kkk-take@ga2.so-net.ne.jp
- Journal
- Invest New Drugs. 2007 Aug;25(4):377-83. Epub 2007 Mar 10.
- Abstract URL
- Click here to view abstract
63. Hypofractionated high-dose proton beam therapy for stage I non-small-cell lung cancer: preliminary results of a phase I/II clinical study.
- Author
- Hata M; Tokuuye K; Kagei K; Sugahara S; Nakayama H; Fukumitsu N; Hashimoto T; Mizumoto M; Ohara K; Akine Y;
- Institution
- Proton Medical Research Center, University of Tsukuba, Tsukuba, Ibaraki, Japan. mhata@syd.odn.ne.jp
- Journal
- Int J Radiat Oncol Biol Phys. 2007 Jul 1;68(3):786-93. Epub 2007 Mar 26.
- Abstract URL
- Click here to view abstract
64. Closeness to death and quality of life in advanced lung cancer patients.
- Author
- Brown S; Thorpe H; Napp V; Brown J;
- Institution
- Clinical Trials Research Unit, University of Leeds, 17 Springfield Mount, Leeds LS2 9NG, UK. s.brown@leeds.ac.uk
- Journal
- Clin Oncol (R Coll Radiol). 2007 Jun;19(5):341-8. Epub 2007 Mar 26.
- Abstract URL
- Click here to view abstract
65. Factorial phase III randomised trial of rofecoxib and prolonged constant infusion of gemcitabine in advanced non-small-cell lung cancer: the GEmcitabine-COxib in NSCLC (GECO) study.
- Author
- Gridelli C; Gallo C; Ceribelli A; Gebbia V; Gamucci T; Ciardiello F; Carozza F; Favaretto A; Daniele B; Galetta D; Barbera S; Rosetti F; Rossi A; Maione P; Cognetti F; Testa A; Di Maio M; Morabito A; Perrone F;
- Institution
- Medical Oncology, S Giuseppe Moscati Hospital, Avellino, Italy. cgridelli@libero.it
- Journal
- Lancet Oncol. 2007 Jun;8(6):500-12.
- Abstract URL
- Click here to view abstract
66. Concurrent celecoxib versus placebo in patients with stage II-III non-small cell lung cancer: a randomised phase II trial.
- Author
- De Ruysscher D; Bussink J; Rodrigus P; Kessels A; Dirx M; Houben R; Wanders R;
- Institution
- MAASTRO Clinic, Maastricht, The Netherlands. dirk.deruysscher@maastro.nl
- Journal
- Radiother Oncol. 2007 Jul;84(1):23-5. Epub 2007 May 25.
- Abstract URL
- Click here to view abstract
67. The value of combined-modality therapy in elderly patients with stage III nonsmall cell lung cancer.
- Author
- Schild SE; Mandrekar SJ; Jatoi A; McGinnis WL; Stella PJ; Deming RL; Jett JR; Garces YI; Allen KL; Adjei AA;
- Institution
- Department of Radiation Oncology, Mayo Clinic and Mayo Foundation, Rochester, Minnesota, USA. sschild@mayo.edu
- Journal
- Cancer. 2007 Jul 15;110(2):363-8.
- Abstract URL
- Click here to view abstract
68. Chemotherapy in patients > or = 80 with advanced non-small cell lung cancer: combined results from SWOG 0027 and LUN 6.
- Author
- Hesketh PJ; Lilenbaum RC; Chansky K; Dowlati A; Graham P; Chapman RA; Crowley JJ; Gandara DR;
- Institution
- Caritas St. Elizabeth's Medical Center of Boston, Boston, Massachusetts 02135, USA. phesketh@massmed.org
- Journal
- J Thorac Oncol. 2007 Jun;2(6):494-8.
- Abstract URL
- Click here to view abstract
69. A phase II trial of carboplatin/vinorelbine with pegfilgrastim support for the treatment of patients with advanced non-small cell lung cancer.
- Author
- Riedel RF; Andrews C; Garst J; Dunphy F; Herndon JE 2nd; Blackwell S; Barbour S; Crawford J;
- Institution
- Ruth and Herman Albert Thoracic Oncology Program, Duke University Medical Center, Durham, North Carolina 27710, USA.
- Journal
- J Thorac Oncol. 2007 Jun;2(6):520-5.
- Abstract URL
- Click here to view abstract
70. Independent review of interstitial lung disease associated with death in TRIBUTE (paclitaxel and carboplatin with or without concurrent erlotinib) in advanced non-small cell lung cancer.
- Author
- Yoneda KY; Shelton DK; Beckett LA; Gandara DR;
- Institution
- Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, UC Davis School of Medicine, Sacramento, California 95817, USA. kyyoneda@ucdavis.edu
- Journal
- J Thorac Oncol. 2007 Jun;2(6):537-43.
- Abstract URL
- Click here to view abstract
Next: Radiation Therapy
